Literature DB >> 12883156

The wound infection continuum and its application to clinical practice.

Andrew Kingsley1.   

Abstract

Four basic conditions exist in open wounds resulting from the level of bioburden present (bacterial contamination--normal but short-lived state, colonization--normal state, critical colonization--abnormal state, and infection--abnormal state). The two abnormal states have the potential to disrupt the orderly healing sequence, which results in the development of a chronic wound. In addition, the impact of the wound s anatomical position, duration, shape, or presentation; the patient s level of health and control of underlying pathologies; the presence of infection-potentiating factors such as foreign bodies, hematoma, and necrotic tissue; the sources and frequency of exogenous contamination; the considered virulence of the individual micro-flora species; and the potential synergism between different species all require consideration. This article discusses the states of bioburden and other aspects of microbiology relating to wound infection and their application to clinical practice.

Entities:  

Mesh:

Year:  2003        PMID: 12883156

Source DB:  PubMed          Journal:  Ostomy Wound Manage        ISSN: 0889-5899            Impact factor:   2.629


  14 in total

1.  The silver-releasing foam dressing, Contreet Foam, promotes faster healing of critically colonised venous leg ulcers: a randomised, controlled trial.

Authors:  Bo Jørgensen; Patricia Price; Klaus E Andersen; Finn Gottrup; Niels Bech-Thomsen; Elizabeth Scanlon; Robert Kirsner; Henriette Rheinen; Jytte Roed-Petersen; Marco Romanelli; Gregor Jemec; David J Leaper; Martino Ha Neumann; Joep Veraart; Stefan Coerper; Rikke H Agerslev; Susanne H Bendz; Jan R Larsen; R Gary Sibbald
Journal:  Int Wound J       Date:  2005-03       Impact factor: 3.315

2.  Antimicrobial activity of silver-containing dressings on wound microorganisms using an in vitro biofilm model.

Authors:  Steven L Percival; Phillip G Bowler; Jayne Dolman
Journal:  Int Wound J       Date:  2007-06       Impact factor: 3.315

Review 3.  The clinical efficacy of two semi-quantitative wound-swabbing techniques in identifying the causative organism(s) in infected cutaneous wounds.

Authors:  Donna E Angel; Peter Lloyd; Keryln Carville; Nick Santamaria
Journal:  Int Wound J       Date:  2011-02-09       Impact factor: 3.315

Review 4.  The detrimental impact of extracellular bacterial proteases on wound healing.

Authors:  Sharon Lindsay; Angela Oates; Katie Bourdillon
Journal:  Int Wound J       Date:  2017-07-25       Impact factor: 3.315

5.  A prospective randomised open label study to evaluate the potential of a new silver alginate/carboxymethylcellulose antimicrobial wound dressing to promote wound healing.

Authors:  Hilde Beele; Frans Meuleneire; Marc Nahuys; Steven L Percival
Journal:  Int Wound J       Date:  2010-05-31       Impact factor: 3.315

6.  [Microbial stress of skin and wounds in clinical aspects and practice. Between search and destroy and monitor and relax].

Authors:  G Daeschlein; S Lutze; M Jünger
Journal:  Hautarzt       Date:  2014-01       Impact factor: 0.751

Review 7.  The diagnosis of infection in chronic leg ulcers: A narrative review on clinical practice.

Authors:  Ut T Bui; Kathleen Finlayson; Helen Edwards
Journal:  Int Wound J       Date:  2019-01-29       Impact factor: 3.315

8.  In vitro assessment of the antimicrobial activity of wound dressings: influence of the test method selected and impact of the pH.

Authors:  Cornelia Wiegand; Martin Abel; Peter Ruth; Peter Elsner; Uta-Christina Hipler
Journal:  J Mater Sci Mater Med       Date:  2015-01-13       Impact factor: 3.896

Review 9.  Optimising antimicrobial therapy in diabetic foot infections.

Authors:  Nalini Rao; Benjamin A Lipsky
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 10.  Venous leg ulcers - the search for a prognostic indicator.

Authors:  Keith Moore; Elizabeth Huddleston; Michael C Stacey; Keith G Harding
Journal:  Int Wound J       Date:  2007-06       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.